AbbVie to Participate in 34th Annual Goldman Sachs Global Healthcare Conference

     AbbVie to Participate in 34th Annual Goldman Sachs Global Healthcare
                                  Conference

PR Newswire

NORTH CHICAGO, Ill., June 5, 2013

NORTH CHICAGO, Ill., June 5, 2013 /PRNewswire/ --AbbVie (NYSE: ABBV) will
participate in the 34^th Annual Goldman Sachs Global Healthcare Conference on
Thursday, June 13, 2013. Bill Chase, executive vice president and chief
financial officer, and Scott Brun, M.D., vice president, pharmaceutical
development, will take part in a question and answer session at 12:40 p.m.
Central time.

A live audio webcast of the question and answer session will be accessible
through AbbVie's Investor Relations Web site at www.abbvieinvestor.com. An
archived edition of the session will be available later that day.

About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013
following separation from Abbott. The company's mission is to use its
expertise, dedicated people and unique approach to innovation to develop and
market advanced therapies that address some of the world's most complex and
serious diseases. In 2013, AbbVie employs approximately 21,000 people
worldwide and markets medicines in more than 170 countries. For further
information on the company and its people, portfolio and commitments, please
visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our
Facebookor LinkedIn page.

SOURCE AbbVie

Website: http://www.abbvie.com
Website: http://www.abbvieinvestor.com
Contact: Media: Adelle Infante, (847) 938-8745 or Investors: Liz Shea, (847)
935-2211
 
Press spacebar to pause and continue. Press esc to stop.